Profile of European Biotechnology & Healthcare Venture Capital Funds

Europe is also a major base to raise capital for your biotechnology or healthcare related projects – as it has many of the world’s largest medical companies, here are some ideas for those interested in the European biotechnology / life-science venture capital market. 

SV Life Sciences

SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. 

These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services.

Imperial Innovations

Imperial Innovations is one of the UK's leading technology commercialisation and investment companies. Founded in 1986 and admitted to the AIM Market of the London Stock Exchange in 2006. 

Imperial Innovations' access to early stage technology and intellectual property is unparalleled. Imperial Innovations' integrated commercialisation approach encompasses the identification of ideas, the protection of intellectual property, the development and licensing of technology and the formation, incubation and funding, through investment, of technology businesses.

The Roche Venture Fund

The Roche Venture Fund makes investments in early stage biotech and diagnostics companies to support innovative technologies and medicines. Based in Basel, Switzerland, the Roche Venture Fund manages a portfolio of over 30 companies in 10 countries.

There are many advantages to be affiliated or invested by the Roche Venture Fund, the close tie with one of the world’s largest pharmaceuticals groups can also bring significant benefits in terms of commercialization, marketing and distribution; as well accessing to world-class research facilities. 

There are similar programs & venture capital funds attached to largest pharmaceutical groups, including most of the large pharmaceutical groups in Europe, this is a good strategy for early stage companies to consider. 

VI Partners

VI Partners is a Swiss venture capital firm that supports university spin-off's as well as other promising start-up companies with capital, coaching, consulting and networks. 

Via its current "Venture Incubator" fund, VI Partners invests "Smart Money" to develop promising technology-based ideas for products and services into successful businesses. 

Venture Incubator was established by McKinsey & Company and the Swiss Federal Institute of Technology in Zürich (ETHZ), and started operations in 2001. It now manages an investment fund of CHF 101 million; and the portfolio and funds under management has been growing consistently. 

We will continue to cover more biotechnology & healthcare venture capital and private equity investors from different regions in our future articles. 

Are you interested to find out more information about investors in biotechnology sectors?

Check out the following reports from us:

European Medical Investors Guide – which includes information on many European venture capital & private equity investors active in the medical sectors. 

Global Biotechnology Capital Providers Guide – this is our most popular report which covers investors in Americas, Asia and Europe. 

More information can be found on our website: http://researchwhitepaper.com